Autolus Therapeutics's market cap is currently $447.12M. The company's EPS TTM is $-0.18; its P/E ratio is ―; Autolus Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
